Found 14 matching trials
Paxil CR Bioequivalence Study Brazil
PHASE1The study is prospective, open, randomized, crossover in steady state and t...
Location
GSK Investigational Site
Single Dose Pharmacokinetic (PK) Study Of Paroxetine CR(12.5-37.5mg) In Healthy Chinese Subjects
PHASE1The study was designed to describe the relationship between dose and pharma...
Location
GSK Investigational Site
Single Dose Study of Controlled-Release Paroxetine Tablets in Healthy Japanese Male Subjects
PHASE1The primary purpose of this study is to to assess the pharmacokinetics of p...
Location
GSK Investigational Site
Fasting Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mg
PHASE1The objective of this study was to investigate the bioequivalence of Mylan'...
Location
PRACS Institute, Ltd.
A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder
PHASE3Major depressive disorder (MDD) is a serious medical illness associated wit...
Location
For additional information regarding sites, contact 844-687-8522
Food Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mg
PHASE1The objective of this study was to investigate the bioequivalence of Mylan'...
Location
PRACS Institute, Ltd.
Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)
PHASE3To assess the long-term safety and tolerability of oral OPC-34712 (brexpipr...
Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome Patients
PHASE4This is an open label, randomized, add-on, 8 weeks multicentre study to eva...
Location
Multiple Locations
A Repeat Dose Pharmacokinetic Study Of Paroxetine CR Tablet In Healthy Chinese Subjects
PHASE1The study was designed to assess the steady-state pharmacokinetic profile o...
Location
GSK Investigational Site
PAXIL CR Bioequivalence Study
PHASE1This study is to determine if controlled release paroxetine tablets manufac...
Location
GSK Investigational Site